In the latter study, the increment of HO-1 following the severity of the disease may suggest a pathophysiological role of HO-1 in NAFLD, however, as in other inflammatory diseases, it is a protective defense [126]. The gene discussed is HMOX1; the disease is metabolic dysfunction-associated steatotic liver disease.